A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma

NCT04017130 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped Sparse/no patient enrollment

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG: MT-0169

Sponsor

Molecular Templates, Inc.